Researchers sought to determine whether elranatamab would lead to durable responses in patients with relapsed or refractory multiple myeloma.

The effectiveness of the Interaktor app was evaluated in a randomized trial of patients undergoing radiotherapy for prostate cancer monitor and manage their symptoms.

Lower mortality risk seen for those who improved guideline concordance after diagnosis or maintained high concordance.

Researchers explained that treatment omission or discontinuation in the adjuvant setting was primarily due to postoperative complications and toxicity “but also to patient-related factors, ...

Researchers conducted a retrospective cohort study to assess the prevalence of normal thyroid function 3 years post-thyroidectomy among patients with thyroid cancer.

African American (AA) individuals with chronic lymphocytic leukemia (CLL) may have more high-risk features and unique genomic characteristics compared with European patients.

These compelling overall survival results from the FLAURA2 trial confirm osimertinib plus chemotherapy as the first-line standard of care in EGFR- advanced non-small cell lung cancer,” said study ...

To our knowledge, SunRISe-4 shows, for the first time, a benefit of the addition of the localised TAR-200 gemcitabine intravesical system to systemic checkpoint inhibition as neoadjuvant treatment in ...

Inlexzo is supplied as a single-dose intravesical system containing 225mg of gemcitabine plus a sterile urinary catheter and stylet.

A review of machine learning (ML) models developed to support the management of chronic lymphocytic leukemia (CLL) have demonstrated positive outcomes, including accurate diagnosis and improved work ...

Responses regarding novel therapies and genetic mutations were often found to lack relevant details or were not up to date, reflecting either insufficient knowledge, outdated resources, or limited ...

HealthDay News — Women who do not participate in their first eligible mammogram screening have a long-term risk for dying from breast cancer, according to a study published online Sept. 24 in The BMJ.